admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Optimi Health Completes Pre-Clinical Trial Application Meeting

PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™...

Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch...

PT248 – Pierre Bouchard – Somatic Therapy, Trauma, and the Nervous...

Psychedelic Research Bulletin: May 2021

Psychedelic Bulletin: MindMed CEO Steps Down; Atai Targets $2.3bn Valuation

Filament Announces First GMP Batch of Pharmaceutical Grade Natural Psilocybin

PTSF63 – The Media and Legalization, Joints for Jabs, and 40,000...

Atai Targets $2.3bn Valuation in Nasdaq IPO

atai Life Sciences Announces Launch of Initial Public Offering

1...210211212...218 Page 211 of 218

EDITOR PICKS

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in...

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin